Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy

NCT02379780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-03-06

No results posted yet for this study

Summary

The investigators aimed to compare the effects of perioperative anesthesia consumption of ultrasound guided subcostal transversus abdominis plane and paravertebral block in laparoscopic cholecystectomy.

Conditions

  • Cholecystitis

Interventions

PROCEDURE

USG guided Subcostal TAP block

Ultrasonography Assisted Subcostal TAP blockage: In plane technique was applied and 22 G needle (BRAUN Stimuplex D Plus 0,71\*50 mm 22G\*2) was used. Intravascular injection was eliminated after the passage of rectus sheath by negative aspiration. 0,5-1 ml local anesthetic was applied directly to confirm the right place. 10 cc bupivacain ( 0,5 % Marcain flacon, Astra Zeneca, Sweeden) and 5 cc lidocaine was injected to the site. The same procedure was applied to the opposite site. we investigated amount of TIVA during the operation, postoperative Visual Analog Scores and the time that the pain free time.

PROCEDURE

USG guided Paravertebral Block

Ultrasonoraphy assisted Thoracic Paravertebral blockage application: In-plane or out-of-plane technique was used with stimuplex needle (BRAUN Stimuplec D Plus 0,71\*50 mm 22 G\* 2'', 15°). Popping sensation that was felt by the penetration of the internal intercostal membrane, guided to paravertebral space. Intravascular injection was eliminated by negative aspiration. 0,5 - 1 ml local anesthetic injection was administered to show the displacement of pleura downward that confirmed the place of the needle in the right place. Then 10 cc bupivacain (% 0.5 Marcaine® flacon, Astra Zeneca, Sweeden) and 5 cc lidocaine was injected to the site. we investigated amount of TIVA during the operation, postoperative Visual Analog Scores and the time that the pain free time.

Sponsors & Collaborators

  • Erzincan University

    collaborator OTHER
  • Cukurova University

    lead OTHER

Principal Investigators

  • ILKE KUPELI · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • ZEHRA BEDİR · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • HUSEYIN EKEN · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • UFUK KUYRUKLUYILDIZ · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • DIDEM ONK · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • ORHAN BINICI · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • AYSIN ALAGOL · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

  • GULDANE KARABAKAN · MENGUCEK GAZI TRAINING AND RESEARCH HOSPİTAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-01-31
Completion
2015-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379780 on ClinicalTrials.gov